Predicting which children benefit from fluid treatment after heart surgery
Official title: Parameters Associated With Metabolic Response to Volume Expansion in Children Post-operative of Cardiac Surgery
Run by University Hospital, Bordeaux · NCT07255469 · Data updated 2026-11-12
This study will test whether a simple blood gas ratio (Pv–aCO2/CavO2) can tell which children in intensive care after cardiac surgery will increase their oxygen use after a 10 ml/kg fluid bolus.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Days to 15 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 8 sites (Bron, France and 7 other locations) |
| Status | Recruiting |
| Started | March 21, 2025 |
| Main results expected | March 21, 2027 |
| Study ends | April 18, 2027 |
| Registry record updated | December 1, 2025 |
| Trial ID | NCT07255469 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children ≤15 years old in a participating pediatric ICU after cardiac surgery who have arterial and central venous lines and are prescribed a 10 ml/kg fluid expansion.
✕Probably not a fit
Preterm infants under 37 weeks corrected gestational age, patients too unstable to delay care or without required vascular access, and those with contraindications to supine positioning or echocardiography are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will enroll children up to 15 years old in pediatric intensive care after cardiac surgery who have functioning arterial and central venous lines and for whom a 10 ml/kg fluid bolus is prescribed. Baseline arterial and central venous blood gases will be collected to calculate the Pv–aCO2/CavO2 ratio, and oxygen consumption (VO2) will be measured before and after the fluid expansion. The main analysis will determine how accurately the baseline Pv–aCO2/CavO2 ratio predicts a significant increase in VO2 (metabolic fluid responsiveness). The study is observational and uses routine clinical care and timed blood sampling without altering standard treatment decisions.
Why it matters
Potential benefit: If successful, clinicians could target fluid therapy to children who will truly improve oxygen delivery and avoid harmful fluid overload in others.
How similar studies have gone: Similar blood-gas–based markers have shown promise in adult studies, but the Pv–aCO2/CavO2 ratio has not been validated for metabolic fluid responsiveness in children.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age less than or equal to 15 years old * Hospitalization in a pediatric intensive care unit after cardiac surgery * Prescription by the attending physician of a fluid expansion of 10ml/kg * Prescription of arterial and venous blood gas before and after the volume expansion to help manage acute circulatory failure * Patient implanted with a functioning arterial line * Patient implanted with a functioning central venous line in the superior vena cava territory Exclusion Criteria: * Patient less than 37 weeks' corrected gestational age * Hemodynamic instability making the delay necessary for any test dangerous * Supine position contraindicated or deleterious * Impairment of echocardiographic acoustic window or restless patient making ultrasonography impossible * Opposition to participate expressed by the patient or by a parent or legal guardian
Where it's running
-
Hôpital Louis Pradel - Hospices Civils de Lyon
Bron, France, France Recruiting -
Hôpital Jeanne de Flandre - CHU de Lille
Lille, France, France Recruiting -
Hôpital mère-enfant - CHU de Nantes
Nantes, France, France Recruiting -
Hôpital Necker-Enfants Malades - Assistance Publique - Hôpitaux de Paris
Paris, France, France Recruiting -
Hôpital Cardiologique Haut Lévêque - CHU de Bordeaux
Pessac, France, France Recruiting -
Hôpital Felix Guyon - CHU de la Réunion
Saint-Denis, La Réunion, France Recruiting
Show 2 more locations
-
Hôpital de la Timone - Assistance Publique - Hôpitaux de Marseille
Marseille, France, France Not yet recruiting -
Hôpital des enfants - CHU de Toulouse
Toulouse, France, France Not yet recruiting
Study contacts
- Study coordinator: Julin GOTCHAC, MD
- Email: julien.gotchac@chu-bordeaux.fr
- Phone: +33 5 24 54 92 19
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Simplified electrical cardiometry test to predict which critically ill children will respond to fluids
This project tests whether a quick, noninvasive electrical cardiometry measurement during a brief abdominal compression can see if critically ill children (≤8 years) will benefit from a 10 ml/kg fluid bolus.
-
Urine Output Monitoring to Guide Fluid and Diuretic Therapy in Cardiac ICU Patients
This observational study tests how continuous urine output data from the FIZE kUO device can help guide fluid therapy and diuretic use in adults after heart surgery.
-
Using 20% albumin with Ringer's lactate during cytoreductive surgery and HIPEC.
This study will test whether adding 20% albumin to Ringer's lactate during cytoreductive surgery with HIPEC for adults with peritoneal carcinomatosis reduces the need for crystalloid fluids and improves postoperative outcomes.
-
Effects of fluid infusion rates on blood circulation during surgery
This study tests how different rates of fluid given during surgery can improve blood flow and oxygen delivery to tissues for patients undergoing elective surgeries with little blood loss.
-
Determining the best IV fluid amount for children after trauma
This study is testing whether giving more or less IV fluid to children after a trauma helps them recover better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.